Pyridoxal kinase and poly(ADP-ribose) affect the immune microenvironment of locally advanced cancers

Malignant cells adapt to the hostile tumor microenvironment by escaping from, or actively suppressing, anticancer immune responses. In the past, we reported that reduced synthesis of active vitamin B6 (due to downregulation of pyridoxal kinase) or overactivation of poly(ADP-ribose) polymerase confer...

Full description

Bibliographic Details
Main Authors: Adrien Joseph, Juncheng Pan, Judith Michels, Guido Kroemer, Maria Castedo
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:OncoImmunology
Subjects:
Online Access:http://dx.doi.org/10.1080/2162402X.2021.1950954
id doaj-b2687f3d74364dbca677d284bbc182ce
record_format Article
spelling doaj-b2687f3d74364dbca677d284bbc182ce2021-07-15T13:10:34ZengTaylor & Francis GroupOncoImmunology2162-402X2021-01-0110110.1080/2162402X.2021.19509541950954Pyridoxal kinase and poly(ADP-ribose) affect the immune microenvironment of locally advanced cancersAdrien Joseph0Juncheng Pan1Judith Michels2Guido Kroemer3Maria Castedo4Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des CordeliersUniversité de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des CordeliersGustave Roussy Cancer CampusUniversité de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des CordeliersUniversité de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des CordeliersMalignant cells adapt to the hostile tumor microenvironment by escaping from, or actively suppressing, anticancer immune responses. In the past, we reported that reduced synthesis of active vitamin B6 (due to downregulation of pyridoxal kinase) or overactivation of poly(ADP-ribose) polymerase confers resistance to chemotherapy with cisplatin. Recently, we found that these prognostically adverse alterations in oncometabolism also correlate with the rarefaction of immune effectors in the tumor bed.http://dx.doi.org/10.1080/2162402X.2021.1950954tumor microenvironmentimmune escapemetabolismvitamin bimmunotherapycd8+ t cellsdendritic cellssurvivalcervical cancernon-small cell lung cancer
collection DOAJ
language English
format Article
sources DOAJ
author Adrien Joseph
Juncheng Pan
Judith Michels
Guido Kroemer
Maria Castedo
spellingShingle Adrien Joseph
Juncheng Pan
Judith Michels
Guido Kroemer
Maria Castedo
Pyridoxal kinase and poly(ADP-ribose) affect the immune microenvironment of locally advanced cancers
OncoImmunology
tumor microenvironment
immune escape
metabolism
vitamin b
immunotherapy
cd8+ t cells
dendritic cells
survival
cervical cancer
non-small cell lung cancer
author_facet Adrien Joseph
Juncheng Pan
Judith Michels
Guido Kroemer
Maria Castedo
author_sort Adrien Joseph
title Pyridoxal kinase and poly(ADP-ribose) affect the immune microenvironment of locally advanced cancers
title_short Pyridoxal kinase and poly(ADP-ribose) affect the immune microenvironment of locally advanced cancers
title_full Pyridoxal kinase and poly(ADP-ribose) affect the immune microenvironment of locally advanced cancers
title_fullStr Pyridoxal kinase and poly(ADP-ribose) affect the immune microenvironment of locally advanced cancers
title_full_unstemmed Pyridoxal kinase and poly(ADP-ribose) affect the immune microenvironment of locally advanced cancers
title_sort pyridoxal kinase and poly(adp-ribose) affect the immune microenvironment of locally advanced cancers
publisher Taylor & Francis Group
series OncoImmunology
issn 2162-402X
publishDate 2021-01-01
description Malignant cells adapt to the hostile tumor microenvironment by escaping from, or actively suppressing, anticancer immune responses. In the past, we reported that reduced synthesis of active vitamin B6 (due to downregulation of pyridoxal kinase) or overactivation of poly(ADP-ribose) polymerase confers resistance to chemotherapy with cisplatin. Recently, we found that these prognostically adverse alterations in oncometabolism also correlate with the rarefaction of immune effectors in the tumor bed.
topic tumor microenvironment
immune escape
metabolism
vitamin b
immunotherapy
cd8+ t cells
dendritic cells
survival
cervical cancer
non-small cell lung cancer
url http://dx.doi.org/10.1080/2162402X.2021.1950954
work_keys_str_mv AT adrienjoseph pyridoxalkinaseandpolyadpriboseaffecttheimmunemicroenvironmentoflocallyadvancedcancers
AT junchengpan pyridoxalkinaseandpolyadpriboseaffecttheimmunemicroenvironmentoflocallyadvancedcancers
AT judithmichels pyridoxalkinaseandpolyadpriboseaffecttheimmunemicroenvironmentoflocallyadvancedcancers
AT guidokroemer pyridoxalkinaseandpolyadpriboseaffecttheimmunemicroenvironmentoflocallyadvancedcancers
AT mariacastedo pyridoxalkinaseandpolyadpriboseaffecttheimmunemicroenvironmentoflocallyadvancedcancers
_version_ 1721300824698650624